The structure and function of the S1P1 receptor

G蛋白偶联受体 S1PR1型 鞘氨醇-1-磷酸受体 生物 细胞生物学 受体 1-磷酸鞘氨醇 视紫红质样受体 芬戈莫德 鞘氨醇激酶 鞘氨醇 信号转导 免疫学 生物化学 癌症研究 多发性硬化 血管内皮生长因子受体 血管内皮生长因子 血管内皮生长因子A 谷氨酸受体 代谢受体
作者
Catherine O’Sullivan,Kumlesh K. Dev
出处
期刊:Trends in Pharmacological Sciences [Elsevier BV]
卷期号:34 (7): 401-412 被引量:121
标识
DOI:10.1016/j.tips.2013.05.002
摘要

•Detailed amino acid analysis of the S1P1 receptor. •Overview of post-translational modification of the S1P1 receptor. •Description of S1P1 receptor internalization and persistent signaling. Sphingosine 1-phosphate (S1P) receptors (S1PRs) belong to the class A family of G protein-coupled receptors (GPCRs). S1PRs are widely expressed on many cell types, including those of the immune, cardiovascular, and central nervous systems. The S1PR family is rapidly gaining attention as an important mediator of many cellular processes, including cell differentiation, migration, survival, angiogenesis, calcium homeostasis, inflammation and immunity. Importantly, S1PRs are known drug targets for multiple sclerosis (MS), for which the newly developed oral therapy fingolimod, an S1PR modulator, has recently been approved for clinical use. Much progress has also recently been made in the field of structural biology and in the modeling of heterotrimeric GPCRs allowing the crystal structure of the S1PR1 subtype to be elucidated and key interactions defined. Here, we outline the structure and function of S1PR1, highlighting the key residues involved in receptor activation, signaling, transmembrane interactions, ligand binding, post-translational modification, and protein–protein interactions. Sphingosine 1-phosphate (S1P) receptors (S1PRs) belong to the class A family of G protein-coupled receptors (GPCRs). S1PRs are widely expressed on many cell types, including those of the immune, cardiovascular, and central nervous systems. The S1PR family is rapidly gaining attention as an important mediator of many cellular processes, including cell differentiation, migration, survival, angiogenesis, calcium homeostasis, inflammation and immunity. Importantly, S1PRs are known drug targets for multiple sclerosis (MS), for which the newly developed oral therapy fingolimod, an S1PR modulator, has recently been approved for clinical use. Much progress has also recently been made in the field of structural biology and in the modeling of heterotrimeric GPCRs allowing the crystal structure of the S1PR1 subtype to be elucidated and key interactions defined. Here, we outline the structure and function of S1PR1, highlighting the key residues involved in receptor activation, signaling, transmembrane interactions, ligand binding, post-translational modification, and protein–protein interactions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Maybe发布了新的文献求助20
刚刚
seedcode完成签到,获得积分10
1秒前
地球发布了新的文献求助10
1秒前
微风完成签到,获得积分10
2秒前
邹邹发布了新的文献求助10
2秒前
chen关注了科研通微信公众号
3秒前
3秒前
5秒前
烟花应助歇儿哒哒采纳,获得10
5秒前
镜子小子完成签到,获得积分10
6秒前
6秒前
CC发布了新的文献求助10
6秒前
所所应助光影采纳,获得10
8秒前
大星完成签到,获得积分10
8秒前
9秒前
共享精神应助iiiorange采纳,获得10
9秒前
10秒前
星辰大海应助guo采纳,获得10
10秒前
10秒前
3333发布了新的文献求助10
11秒前
义气飞机完成签到,获得积分10
11秒前
12A发布了新的文献求助10
12秒前
chen发布了新的文献求助10
14秒前
14秒前
lilyvan完成签到 ,获得积分10
14秒前
赘婿应助随梦而飞采纳,获得10
15秒前
16秒前
17秒前
Cyaccc完成签到,获得积分10
18秒前
18秒前
李健应助邹邹采纳,获得10
19秒前
19秒前
iiiorange发布了新的文献求助10
21秒前
21秒前
CipherSage应助zzz采纳,获得10
21秒前
bfsd凡完成签到,获得积分10
22秒前
斯文鱼发布了新的文献求助10
22秒前
23秒前
zl50268发布了新的文献求助10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
全相对论原子结构与含时波包动力学的理论研究--清华大学 500
Elevating Next Generation Genomic Science and Technology using Machine Learning in the Healthcare Industry Applied Machine Learning for IoT and Data Analytics 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6443580
求助须知:如何正确求助?哪些是违规求助? 8257418
关于积分的说明 17586894
捐赠科研通 5502274
什么是DOI,文献DOI怎么找? 2900939
邀请新用户注册赠送积分活动 1877987
关于科研通互助平台的介绍 1717534